New study tests if MRI-Targeted biopsies are as good as standard ones for finding prostate cancer
NCT ID NCT02050542
First seen Nov 20, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This study compared two ways to detect prostate cancer: using MRI to guide a few targeted biopsies versus the standard method of taking 12 random samples. It involved 108 men aged 45-75 with elevated PSA levels. The goal was to see if the MRI-targeted approach could find cancer just as well as the standard method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Cochin
Paris, 75014, France
-
CHU Grenoble
Grenoble, 38043, France
-
CHU Pitié salpêtrière
Paris, 75013, France
-
CHU Toulouse Rangueil
Toulouse, 31076, France
-
Chu Edouard Herriot
Lyon, 69437, France
-
Clinique Pasteur
Toulouse, 31076, France
Conditions
Explore the condition pages connected to this study.